Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study
In-stent restenosis
Male
Lipoproteins
Cholesterol, VLDL
Coronary Artery Disease
Coronary Angiography
Risk Assessment
Percutaneous coronary intervention
Coronary Restenosis
03 medical and health sciences
Percutaneous Coronary Intervention
0302 clinical medicine
Risk Factors
Type 2 diabetes mellitus
Remnant-like particle cholesterol
Diseases of the circulatory (Cardiovascular) system
Humans
Original Investigation
Aged
Retrospective Studies
Remnant lipoproteins
Cholesterol, LDL
Middle Aged
3. Good health
Cholesterol
Diabetes Mellitus, Type 2
RC666-701
Beijing
Female
Stents
Very-low-density lipoprotein cholesterol
Biomarkers
DOI:
10.1186/s12933-019-0819-z
Publication Date:
2019-01-28T08:02:44Z
AUTHORS (9)
ABSTRACT
Increasing evidence has suggested that the presence of remnant lipoproteins is a significant risk factor for atherosclerosis. Remnant are rich in triglycerides (TGs), and main components include very-low-density lipoprotein (VLDL) fasting state. Diabetic patients often have hypertriglyceridemia with elevated levels VLDL cholesterol but normal low-density (LDL-C). The aim present study was to elucidate potential role lipoproteins-induced atherosclerosis occurrence development in-stent restenosis (ISR) diabetic coronary artery disease. enrolled 2312 type 2 diabetes mellitus who underwent percutaneous intervention from January 2013 December 2014 were followed up by angiography. Patients divided into two groups based on or absence ISR, multivariate Cox’s proportional hazards regression modelling showed remnant-like particle (RLP-C) an independent ISR. According receiver operating characteristic curve, optimal cutoff point RLP-C identified, further groups. Propensity score matching analysis performed, 762 pairs successfully matched. Log-rank tests used compare Kaplan–Meier curves overall follow-up assess independently associated baseline level at 0.505 mmol/L identified as predict RLP levels. After propensity analysis, total matched generated. estimated cumulative rate ISR significantly higher ≥ (log-rank P < 0.001; HR equal 4.175, 95% CI = 3.045–5.723, 0.001) compared mmol/L. emphasized importance cardiovascular pathology patients. Physicians should take measures control below better prevent
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (37)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....